556 related articles for article (PubMed ID: 25791839)
41. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
Maurea S; Cuocolo A; Reynolds JC; Neumann RD; Salvatore M
Q J Nucl Med; 1996 Dec; 40(4):365-71. PubMed ID: 9050342
[TBL] [Abstract][Full Text] [Related]
42. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
43. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
[TBL] [Abstract][Full Text] [Related]
44. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
[TBL] [Abstract][Full Text] [Related]
45. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.
Wiseman GA; Pacak K; O'Dorisio MS; Neumann DR; Waxman AD; Mankoff DA; Heiba SI; Serafini AN; Tumeh SS; Khutoryansky N; Jacobson AF
J Nucl Med; 2009 Sep; 50(9):1448-54. PubMed ID: 19690028
[TBL] [Abstract][Full Text] [Related]
47. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
[TBL] [Abstract][Full Text] [Related]
48. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.
van Gils AP; Falke TH; van Erkel AR; Arndt JW; Sandler MP; van der Mey AG; Hoogma RP
Radiographics; 1991 Jan; 11(1):37-57. PubMed ID: 1671719
[TBL] [Abstract][Full Text] [Related]
49. False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.
Fonte JS; Robles JF; Chen CC; Reynolds J; Whatley M; Ling A; Mercado-Asis LB; Adams KT; Martucci V; Fojo T; Pacak K
Endocr Relat Cancer; 2012 Feb; 19(1):83-93. PubMed ID: 22167067
[TBL] [Abstract][Full Text] [Related]
50. [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
Duet M; Sauvaget E; Guichard JP; Petelle B; Ledjedel S; Herman P; Tran Ba Huy P
Ann Otolaryngol Chir Cervicofac; 2002 Dec; 119(6):315-21. PubMed ID: 12527839
[TBL] [Abstract][Full Text] [Related]
51. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
52. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.
Kopf D; Bockisch A; Steinert H; Hahn K; Beyer J; Neumann HP; Hensen J; Lehnert H
Clin Endocrinol (Oxf); 1997 Jan; 46(1):39-44. PubMed ID: 9059556
[TBL] [Abstract][Full Text] [Related]
53. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.
Meyer-Rochow GY; Schembri GP; Benn DE; Sywak MS; Delbridge LW; Robinson BG; Roach PJ; Sidhu SB
Ann Surg Oncol; 2010 Feb; 17(2):392-400. PubMed ID: 19949879
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
[TBL] [Abstract][Full Text] [Related]
55. The phenotype of
Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
[TBL] [Abstract][Full Text] [Related]
56. [Scintigraphy with iodine-131 metaiodobenzylguanidine in the study of paraganglioma. Comparison between benign and malignant tumors].
Maurea S; Cuocolo A; Reynolds J; Keiser H; Neumann R; Salvatore M
Radiol Med; 1994 May; 87(5):688-93. PubMed ID: 8008902
[TBL] [Abstract][Full Text] [Related]
57. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
58. Meta-[123I]iodobenzylguanidine single photon emission computed tomography in chemodectomas.
Virotta G; Medolago G; Zappone C; Moschini L; Torre L; Mazzoni A; Bertocchi C
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):9-12. PubMed ID: 9002741
[TBL] [Abstract][Full Text] [Related]
59. Complete remission of metastatic pheochromocytoma in
Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
[TBL] [Abstract][Full Text] [Related]
60. Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas.
Pattou FN; Combemale FP; Poirette JF; Carnaille B; Wemeau JL; Huglo D; Ernst O; Proye CA
Surgery; 1996 Dec; 120(6):1006-11; discussion 1012. PubMed ID: 8957487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]